InnovAge Holding Revenue 2020-2025 | INNV
InnovAge Holding revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| InnovAge Holding Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $764 |
| 2023 | $688 |
| 2022 | $699 |
| 2021 | $638 |
| 2020 | $567 |
| 2019 | $466 |
| InnovAge Holding Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $218 |
| 2024-12-31 | $209 |
| 2024-09-30 | $205 |
| 2024-06-30 | $199 |
| 2024-03-31 | $193 |
| 2023-12-31 | $189 |
| 2023-09-30 | $182 |
| 2023-06-30 | $177 |
| 2023-03-31 | $173 |
| 2022-12-31 | $167 |
| 2022-09-30 | $171 |
| 2022-06-30 | $173 |
| 2022-03-31 | $177 |
| 2021-12-31 | $175 |
| 2021-09-30 | $173 |
| 2021-06-30 | $172 |
| 2021-03-31 | $156 |
| 2020-12-31 | $157 |
| 2020-09-30 | $153 |
| 2020-06-30 | |
| 2020-03-31 | $145 |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.590B | $0.764B |
| InnovAge Holding Corp. is a healthcare delivery platform. The Company delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors as well as it serve participants primarily through Program of All-inclusive Care for the Elderly. InnovAge Holding Corp. is based in DENVER, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.339B | 25.95 |
| CVS Health (CVS) | United States | $80.708B | 10.03 |
| Elevance Health (ELV) | United States | $77.846B | 10.05 |
| Cencora (COR) | United States | $57.726B | 20.08 |
| DiDi Global (DIDIY) | China | $28.851B | 30.65 |
| Labcorp Holdings (LH) | United States | $20.589B | 16.70 |
| Natera (NTRA) | United States | $20.264B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $12.835B | 0.00 |
| Solventum (SOLV) | United States | $12.635B | 13.38 |
| ICON (ICLR) | Ireland | $11.632B | 10.81 |
| Revvity (RVTY) | United States | $11.186B | 19.25 |
| Viatris (VTRS) | United States | $10.657B | 3.66 |
| Medpace Holdings (MEDP) | United States | $9.049B | 24.03 |
| Sonic Healthcare (SKHHY) | Australia | $8.827B | 0.00 |
| Avantor (AVTR) | United States | $8.763B | 12.73 |
| HealthEquity (HQY) | United States | $8.446B | 37.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.988B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.610B | 14.91 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.902B | 37.73 |
| Alignment Healthcare (ALHC) | United States | $2.649B | 0.00 |
| Concentras Parent (CON) | United States | $2.522B | 14.58 |
| Organon (OGN) | United States | $2.503B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.296B | 88.43 |
| Progyny (PGNY) | United States | $1.973B | 43.43 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Premier (PINC) | United States | $1.730B | 13.13 |
| Ardent Health (ARDT) | United States | $1.718B | 7.32 |
| GoodRx Holdings (GDRX) | United States | $1.700B | 34.00 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.263B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.101B | 8.38 |
| CareDx (CDNA) | United States | $1.069B | 16.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.894B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.754B | 7.06 |
| Nutex Health (NUTX) | United States | $0.578B | 8.75 |
| Embecta (EMBC) | United States | $0.570B | 3.84 |
| SBC Medicals (SBC) | United States | $0.543B | 0.00 |
| So-Young (SY) | China | $0.530B | 0.00 |
| LifeMD (LFMD) | United States | $0.514B | 0.00 |
| Omada Health (OMDA) | $0.476B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.368B | 0.00 |
| Enhabit (EHAB) | United States | $0.346B | 28.50 |
| Performant Healthcare (PHLT) | United States | $0.318B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.112B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.074B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |